Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $168.83 million. The enterprise value is $165.70 million.
Important Dates
The next estimated earnings date is Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 86.14 million shares outstanding. The number of shares has increased by 7.52% in one year.
| Shares Outstanding | 86.14M |
| Shares Change (YoY) | +7.52% |
| Shares Change (QoQ) | +1.31% |
| Owned by Insiders (%) | 11.55% |
| Owned by Institutions (%) | 30.79% |
| Float | 59.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.91 |
| Forward PS | 4.72 |
| PB Ratio | 14.40 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.29 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.89% and return on invested capital (ROIC) is -49.62%.
| Return on Equity (ROE) | -94.89% |
| Return on Assets (ROA) | -32.18% |
| Return on Capital (ROIC) | -49.62% |
| Revenue Per Employee | $194,639 |
| Profits Per Employee | -$181,000 |
| Employee Count | 122 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.01% in the last 52 weeks. The beta is 1.55, so Stereotaxis's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +34.01% |
| 50-Day Moving Average | 2.04 |
| 200-Day Moving Average | 2.19 |
| Relative Strength Index (RSI) | 45.66 |
| Average Volume (20 Days) | 209,609 |
Short Selling Information
The latest short interest is 3.27 million, so 3.80% of the outstanding shares have been sold short.
| Short Interest | 3.27M |
| Short Previous Month | 3.23M |
| Short % of Shares Out | 3.80% |
| Short % of Float | 5.50% |
| Short Ratio (days to cover) | 15.41 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $23.75 million and -$22.08 million in losses. Loss per share was -$0.27.
| Revenue | 23.75M |
| Gross Profit | 14.08M |
| Operating Income | -21.71M |
| Pretax Income | -19.87M |
| Net Income | -22.08M |
| EBITDA | -21.15M |
| EBIT | -21.71M |
| Loss Per Share | -$0.27 |
Full Income StatementBalance Sheet
The company has $14.68 million in cash and $5.28 million in debt, giving a net cash position of $9.40 million or $0.11 per share.
| Cash & Cash Equivalents | 14.68M |
| Total Debt | 5.28M |
| Net Cash | 9.40M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 16.76M |
| Book Value Per Share | 0.14 |
| Working Capital | 15.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.84 million and capital expenditures -$32,000, giving a free cash flow of -$8.87 million.
| Operating Cash Flow | -8.84M |
| Capital Expenditures | -32,000 |
| Free Cash Flow | -8.87M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 59.28%, with operating and profit margins of -91.43% and -87.38%.
| Gross Margin | 59.28% |
| Operating Margin | -91.43% |
| Pretax Margin | -87.38% |
| Profit Margin | -87.38% |
| EBITDA Margin | -89.06% |
| EBIT Margin | -91.43% |
| FCF Margin | -32.10% |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.52% |
| Shareholder Yield | -7.52% |
| Earnings Yield | -13.01% |
| FCF Yield | -5.23% |
Analyst Forecast
The average price target for Stereotaxis is $4.50, which is 129.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 129.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 11, 2012. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jul 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
Stereotaxis has an Altman Z-Score of -17.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.37 |
| Piotroski F-Score | 3 |